Peter Devilee

发表

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | NOVA. The University of Newcastle's Digital Repository

Rosemary L. Balleine, Christine L. Clarke, D. Gareth Evans, 2014 .

Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer

Bin Liu, Bernd Holleczek, William J. Howat, 2015, EBioMedicine.

Advances in paraganglioma-pheochromocytoma cell lines and xenografts.

Peter Devilee, Jean-Pierre Bayley, P. Devilee, 2020, Endocrine-related cancer.

Making sense of big data in health research: Towards an EU action plan

Magnus Rattray, Thomas Lengauer, Haralampos Karanikas, 2016, Genome Medicine.

High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium

Peter Devilee, Arto Mannermaa, Annegien Broeks, 2016, The journal of pathology. Clinical research.

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

Peter Kraft, Todd L Edwards, Nazneen Rahman, 2016, Cancer discovery.

Bmc Cancer

Leila Mohammadi, Peter Devilee, Hans C van Houwelingen, 2022 .

Identification of Novel Genetic Markers of Breast Cancer Survival

Peter Kraft, Nazneen Rahman, Janet A. Dunn, 2015, Journal of the National Cancer Institute.

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting

Peter Devilee, Caroline Seynaeve, Geertruida H de Bock, 2008, BMC Cancer.

SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma

Steven P. Gygi, Peter Devilee, Jared Rutter, 2009, Science.

Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.

Peter Devilee, Päivi Laiho, Lauri A Aaltonen, 2007, International journal of cancer.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Michael Jones, Peter Kraft, Arnaud Droit, 2017, Nature Genetics.

Identification of the breast cancer susceptibility gene BRCA2

Julian Peto, Peter Devilee, Rosalind Eeles, 1996, Nature.

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

Peter Kraft, Michael Bremer, Simon S. Cross, 2008, PLoS genetics.

Association of ESR1 gene tagging SNPs with breast cancer risk.

Julian Peto, Ute Hamann, Peter Devilee, 2009, Human molecular genetics.

The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.

Dongxin Lin, Peter Devilee, Caroline Seynaeve, 2011, Cancer cell.

Subtypes of familial breast tumours revealed by expression and copy number profiling

Stephen Fox, Peter Devilee, Peter T. Simpson, 2010, Breast Cancer Research and Treatment.

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

Matthias W. Beckmann, Peter A. Fasching, Simon S. Cross, 2016, American journal of human genetics.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma

Peter Devilee, Edward Blair, Jean-Pierre Bayley, 2006, BMC Medical Genetics.

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

Daniel J. Park, Julian Peto, Kamila Czene, 2012, Cancer research.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Mads Thomassen, Nina Ditsch, Dieter Niederacher, 2009, Human molecular genetics.

Pathology and Genetics of Tumours of the Breast and Female Genital Organs

Peter Devilee, P. Devilee, F. Tavassoli, 2003 .

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

Gary D. Bader, Christine L. Clarke, Gary D Bader, 2020, Nature Communications.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Wei Lu, Wei Zheng, Mads Thomassen, 2013, Nature Genetics.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

Nazneen Rahman, Carel Meijers, Julian Peto, 2002, Nature Genetics.

Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.

Peter Devilee, Lodewyk F A Wessels, Tibor van Welsem, 2005, Cancer research.

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

Peter Devilee, Ronald van Eijk, Tamara Peelen, 1997, Nature Genetics.

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival

Bernd Holleczek, Peter A. Fasching, Simon S. Cross, 2015, Oncotarget.

Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

Julian Peto, Ute Hamann, Peter Devilee, 2005, Clinical Cancer Research.

Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170

Wei Zheng, Mads Thomassen, Nicholas A. Sinnott-Armstrong, 2016 .

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Christiana Kartsonaki, Mads Thomassen, Julian Peto, 2010, Nature Genetics.

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

Patrick Neven, Päivi Heikkilä, Giu-Cheng Hsu, 2011, Human molecular genetics.

COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration

Peter Kraft, Mads Thomassen, Daniel J. Park, 2013, Breast Cancer Research.

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Olufunmilayo I. Olopade, Mads Thomassen, Torben A. Kruse, 2014, PLoS genetics.

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

Joshua M. Korn, Christiana Kartsonaki, Amanda B. Spurdle, 2010, PLoS Genetics.

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

Peter Devilee, Alfons Meindl, Lesley McGuffog, 2010, Breast Cancer Research.

Deep sequencing to reveal new variants in pooled DNA samples

Detlef Weigel, Johan T den Dunnen, Jelle J Goeman, 2009, Human mutation.

A tiny step closer to personalized risk prediction for breast cancer.

Peter Devilee, P. Devilee, M. Rookus, 2010, The New England journal of medicine.

A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer

Peter Devilee, Javier Benitez, Roger L. Milne, 2009, Breast Cancer Research and Treatment.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice‐site prediction programs

Peter Devilee, P. Devilee, C. V. van Asperen, 2009, Human mutation.

Gene-panel sequencing and the prediction of breast-cancer risk.

Nazneen Rahman, Peter Devilee, Alfons Meindl, 2015, The New England journal of medicine.

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.

Julian Peto, Kyriaki Michailidou, Thomas Brüning, 2014, Human molecular genetics.

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Patrick Neven, Peter Kraft, Nazneen Rahman, 2015 .

Erratum to: Making sense of big data in health research: towards an EU action plan

Magnus Rattray, Thomas Lengauer, Haralampos Karanikas, 2016, Genome Medicine.

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.

Wei Lu, Päivi Heikkilä, Peter Kraft, 2013, American journal of human genetics.

BMC Cancer

Leila Mohammadi, Peter Devilee, H. V. van Houwelingen, 2001 .

Leiden open variation database of the MUTYH gene

Peter Devilee, Florentia Fostira, Riccardo Fodde, 2010, Human mutation.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS

Dong Liang, Jane E. Carpenter, Peter Kraft, 2016 .

Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

Marc Vidal, Dieter Niederacher, Roderic Guigó, 2011, PLoS biology.

The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency

Peter Devilee, Jean-Pierre Bayley, P. Devilee, 2005, BMC Medical Genetics.

11q13 is a susceptibility locus for hormone receptor positive breast cancer

Patrick Neven, Michael Jones, Michael Bremer, 2012, Human mutation.

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

Wei Lu, Nina Ditsch, Julian Peto, 2013, American journal of human genetics.

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

Matthias W. Beckmann, Peter A. Fasching, Nur Aishah Mohd Taib, 2014, Nature Communications.

Genome-wide association analysis identifies three new breast cancer susceptibility loci

Michael Jones, Nazneen Rahman, Daniel J. Park, 2012, Nature Genetics.